(Q78385769)
English
Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal
scientific article published on 01 November 2002
Statements
Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up (English)
Maria Concetta Petti
Francesco Lo-Coco
Maria Luce Vegna
Michele Baccarani
Nicola Cantore
Eros Di Bona
Felicetto Ferrara
Giuseppe Fioritoni
Eugenio Gallo
Rosangela Invernizzi
Mario Lazzarino
Vincenzo Liso
Guglielmo Mariani
Francesco Ricciuti
Carmine Selleri
Simona Sica
Dino Veneri
Franco Mandelli
GIMEMA (Gruppo Italiano Malattie Ematologische dell'Adulto) Italian Cooperative Group
1 November 2002